Haibin Li1, Zhian Jiang1, Xiangdong Liu2, Zhihui Yang1. 1. Department of Cardiology, Third Affiliated Hospital of Hebei Medical University Hebei, China. 2. Department of International Radiology, Third Affiliated Hospital of Hebei Medical University Hebei, China.
Abstract
OBJECT: Percutaneous Coronary Intervention (PCI) is one of the most effective treatments for Coronary Heart Disease (CHD), but the high rate of In Stent Restenosis (ISR) has plagued clinicians after PCI. We aim to investigate the correlation of plasma Stromal Interaction Molecular 1 (STIM1) and Osteoprotegerin (OPG) level with stent restenosis after PCI. METHODS: A total of 100 consecutive patients with Coronary Heart Disease (CHD) received PCI procedure were recruited. Coronary angiography was performed 8 months after their PCI. Then patients were divided into 2 groups: observation group was composed by patients who existing postoperative stenosis after intervention; Control group was composed by patients with no postoperative stenosis. The plasma levels of STIM, OPG in all patients were tested before and after intervention. Pearson correlation and multiple linear regression analysis were performed to analysis the correlation between STIM, OPG level and postoperative stenosis. RESULTS: 35 cases were divided into observation group and other 65 were divided into control group. The plasma levels of STIM, OPG have no statistical difference before their PCI procedure, but we observed higher level of High-sensitivity C-reactive protein (Hs-CRP) existed in observation group. We observed higher level of plasma STIM, OPG in observation group when compared with control group after PCI procedure (P < 0.05). Regression analysis demonstrated that Hs-CRP, STIM1, OPG are independent risk factors for ISR. CONCLUSION: Elevated levels of plasma STIM1, OPG are independent risk factors for ISR in patients received PCI, which could provide useful information for the restenosis control after PCI.
OBJECT: Percutaneous Coronary Intervention (PCI) is one of the most effective treatments for Coronary Heart Disease (CHD), but the high rate of In Stent Restenosis (ISR) has plagued clinicians after PCI. We aim to investigate the correlation of plasma Stromal Interaction Molecular 1 (STIM1) and Osteoprotegerin (OPG) level with stent restenosis after PCI. METHODS: A total of 100 consecutive patients with Coronary Heart Disease (CHD) received PCI procedure were recruited. Coronary angiography was performed 8 months after their PCI. Then patients were divided into 2 groups: observation group was composed by patients who existing postoperative stenosis after intervention; Control group was composed by patients with no postoperative stenosis. The plasma levels of STIM, OPG in all patients were tested before and after intervention. Pearson correlation and multiple linear regression analysis were performed to analysis the correlation between STIM, OPG level and postoperative stenosis. RESULTS: 35 cases were divided into observation group and other 65 were divided into control group. The plasma levels of STIM, OPG have no statistical difference before their PCI procedure, but we observed higher level of High-sensitivity C-reactive protein (Hs-CRP) existed in observation group. We observed higher level of plasma STIM, OPG in observation group when compared with control group after PCI procedure (P < 0.05). Regression analysis demonstrated that Hs-CRP, STIM1, OPG are independent risk factors for ISR. CONCLUSION: Elevated levels of plasma STIM1, OPG are independent risk factors for ISR in patients received PCI, which could provide useful information for the restenosis control after PCI.
Entities:
Keywords:
Percutaneous coronary intervention (PCI); high-sensitivity C-reactive protein (Hs-CRP); in stent restenosis (ISR); osteoprotegerin (OPG); stromal interaction molecular 1 (STIM1)
Authors: W S Simonet; D L Lacey; C R Dunstan; M Kelley; M S Chang; R Lüthy; H Q Nguyen; S Wooden; L Bennett; T Boone; G Shimamoto; M DeRose; R Elliott; A Colombero; H L Tan; G Trail; J Sullivan; E Davy; N Bucay; L Renshaw-Gegg; T M Hughes; D Hill; W Pattison; P Campbell; S Sander; G Van; J Tarpley; P Derby; R Lee; W J Boyle Journal: Cell Date: 1997-04-18 Impact factor: 41.582
Authors: Toru Naganuma; Alaide Chieffo; Emanuele Meliga; Davide Capodanno; Seung-Jung Park; Yoshinobu Onuma; Marco Valgimigli; Sanda Jegere; Raj R Makkar; Igor F Palacios; Charis Costopoulos; Young-Hak Kim; Piotr P Buszman; Tarun Chakravarty; Imad Sheiban; Roxana Mehran; Christoph Naber; Ronan Margey; Arvind Agnihotri; Sebastiano Marra; Piera Capranzano; Martin B Leon; Jeffrey W Moses; Jean Fajadet; Thierry Lefevre; Marie-Claude Morice; Andrejs Erglis; Corrado Tamburino; Ottavio Alfieri; Patrick W Serruys; Antonio Colombo Journal: JACC Cardiovasc Interv Date: 2013-12 Impact factor: 11.195
Authors: Helen E Collins; Lan He; Luyun Zou; Jing Qu; Lufang Zhou; Silvio H Litovsky; Qinglin Yang; Martin E Young; Richard B Marchase; John C Chatham Journal: Am J Physiol Heart Circ Physiol Date: 2014-02-28 Impact factor: 4.733